- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Peripheral Intervention Drug-Eluting Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.6% during the forecast period.
This report presents the market size and development trends by detailing the Peripheral Intervention Drug-Eluting Devices market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Peripheral Intervention Drug-Eluting Devices market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Peripheral Intervention Drug-Eluting Devices industry and will help you to build a panoramic view of the industrial development.
Peripheral Intervention Drug-Eluting Devices Market, By Type:
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Peripheral Intervention Drug-Eluting Devices Market, By Application:
Drug-Eluting Balloons
Drug-Eluting Stents
Some of the leading players are as follows:
St. Jude Medical, Inc.
B. Braun Melsungen AG
Biosensors International Group Ltd
C.R. Bard, Inc.
Cardinal Health
Terumo Corporation
St Jude Medical, Inc
CR Bard, Inc
Boston Scientific Corporation
B Braun Melsungen AG.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Peripheral Intervention Drug-Eluting Devices Market: Technology Type Analysis
-
4.1 Peripheral Intervention Drug-Eluting Devices Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Peripheral Intervention Drug-Eluting Devices Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Plain Old Balloon Angioplasty (POBA)
4.3.2 Percutaneous Transluminal Angioplasty (PTA)
5 Peripheral Intervention Drug-Eluting Devices Market: Product Analysis
-
5.1 Peripheral Intervention Drug-Eluting Devices Product Market Share Analysis, 2018 & 2026
-
5.2 Peripheral Intervention Drug-Eluting Devices Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Peripheral Intervention Drug-Eluting Devices Market: Application Analysis
-
6.1 Peripheral Intervention Drug-Eluting Devices Application Market Share Analysis, 2018 & 2026
-
6.2 Peripheral Intervention Drug-Eluting Devices Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Drug-Eluting Balloons
6.3.2 Drug-Eluting Stents
7 Peripheral Intervention Drug-Eluting Devices Market: Regional Analysis
-
7.1 Peripheral Intervention Drug-Eluting Devices Regional Market Share Analysis, 2018 & 2026
-
7.2 Peripheral Intervention Drug-Eluting Devices Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 St. Jude Medical, Inc.
9.1.1 St. Jude Medical, Inc. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 B. Braun Melsungen AG
9.2.1 B. Braun Melsungen AG Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Biosensors International Group Ltd
9.3.1 Biosensors International Group Ltd Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 C.R. Bard, Inc.
9.4.1 C.R. Bard, Inc. Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Cardinal Health
9.5.1 Cardinal Health Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Terumo Corporation
9.6.1 Terumo Corporation Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 St Jude Medical, Inc
9.7.1 St Jude Medical, Inc Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 CR Bard, Inc
9.8.1 CR Bard, Inc Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Boston Scientific Corporation
9.9.1 Boston Scientific Corporation Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 B Braun Melsungen AG.
9.10.1 B Braun Melsungen AG. Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 91 Figures and 146 Tables)
Figure Plain Old Balloon Angioplasty (POBA) Peripheral Intervention Drug-Eluting Devices market, 2015 - 2026 (USD Million)
Figure Percutaneous Transluminal Angioplasty (PTA) Peripheral Intervention Drug-Eluting Devices market, 2015 - 2026 (USD Million)
Figure Drug-Eluting Balloons market, 2015 - 2026 (USD Million)
Figure Drug-Eluting Stents market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Peripheral Intervention Drug-Eluting Devices market, by country, 2015 - 2026 (USD Million)
-
Table North America Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table North America Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table North America Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Canada Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Canada Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Europe Peripheral Intervention Drug-Eluting Devices market, by country, 2015 - 2026 (USD Million)
-
Table Europe Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Europe Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Europe Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Germany Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Germany Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table France Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table France Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Italy Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Italy Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Spain Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Spain Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Peripheral Intervention Drug-Eluting Devices market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table China Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table China Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Japan Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Japan Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table India Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table India Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Peripheral Intervention Drug-Eluting Devices market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table MEA Peripheral Intervention Drug-Eluting Devices market, by country, 2015 - 2026 (USD Million)
-
Table MEA Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table MEA Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table MEA Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Peripheral Intervention Drug-Eluting Devices market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Peripheral Intervention Drug-Eluting Devices market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Peripheral Intervention Drug-Eluting Devices market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table St. Jude Medical, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table B. Braun Melsungen AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biosensors International Group Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table C.R. Bard, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cardinal Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Terumo Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table St Jude Medical, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CR Bard, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boston Scientific Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table B Braun Melsungen AG. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-